tradingkey.logo
tradingkey.logo
Search

Alloy Therapeutics Enters Into Multi-Target Collaboration And License Agreement With Biogen For Use Of Alloy’S Anticlastic™ Aso Platform

ReutersApr 7, 2026 10:07 AM

- Biogen Inc BIIB.O:

  • ALLOY THERAPEUTICS ENTERS INTO MULTI-TARGET COLLABORATION AND LICENSE AGREEMENT WITH BIOGEN FOR USE OF ALLOY’S ANTICLASTIC™ ASO PLATFORM

  • ALLOY: THROUGH THIS COLLABORATION, BIOGEN WILL APPLY PLATFORM TO ADVANCE ANTISENSE THERAPEUTICS AGAINST MULTIPLE UNDISCLOSED TARGETS

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Recommended Articles

Tradingkey
KeyAI